A multicenter phase II study of G17DT immunogen plus irinotecan in pretreated metastatic colorectal cancer progressing on irinotecan
Crossref DOI link: https://doi.org/10.1007/s00280-014-2520-y
Published Online: 2014-07-17
Published Print: 2014-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rocha-Lima, Caio Max
de Queiroz Marques Junior, Eriberto
Bayraktar, Soley
Broome, Paul
Weissman, Charles
Nowacki, Marek
Leslie, Martin
Susnerwala, Shabbir
Text and Data Mining valid from 2014-07-17